Literature DB >> 22294774

Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers.

Noel F C C de Miranda1, Frederik J Hes, Tom van Wezel, Hans Morreau.   

Abstract

Two forms of genomic instability can be distinguished in colorectal cancer (CRC) tumourigenesis. One is characterised by pronounced chromosomal instability (CIN), while the other relates to alterations produced at the nucleotide level that preferentially target microsatellite sequences. Tumours developing under the latter form of genomic instability possess a microsatellite instability-high (MSI-H) phenotype due to inactivation of the DNA mismatch repair system. The most recently described CRC syndrome, MUTYH-associated polyposis (MAP), shares characteristics with both MSI-H and CIN cancers. MAP carcinomas develop from the impairment of the base excision repair system, where MUTYH is involved, but also present a peculiar form of CIN. Several clinicopathological characteristics of MSI-H and MAP CRCs overlap such as tumour location, clinical prognosis and histological features. We propose that MSI-H and MAP CRCs are particularly prone to interact with their tumour microenvironment. A great deal of this interaction is probably stimulated by the immunogenic character of those tumours, known to possess a high mutagenic potential. The accumulation of mutations in coding regions of the genome of MSI-H and MAP carcinomas is likely to translate into a surplus of neo-antigens that trigger an anti-tumour immune response. The immune system constitutes thus an important vector of selective pressure that favours the outgrowth of tumour clones with immune-evasive phenotypes. In this review, we summarise the evidence for the influence of the tumour microenvironment in MSI-H and MAP tumourigenesis. Furthermore, we discuss how particular features of MSI-H and MAP CRCs can be exploited for the development of therapeutic strategies for affected patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294774     DOI: 10.1093/mutage/ger077

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

Review 1.  Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.

Authors:  Douglas M Banda; Nicole N Nuñez; Michael A Burnside; Katie M Bradshaw; Sheila S David
Journal:  Free Radic Biol Med       Date:  2017-01-10       Impact factor: 7.376

Review 2.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

3.  In silico analysis of the transportome in human pancreatic ductal adenocarcinoma.

Authors:  A Zaccagnino; C Pilarsky; D Tawfik; S Sebens; A Trauzold; I Novak; A Schwab; H Kalthoff
Journal:  Eur Biophys J       Date:  2016-09-21       Impact factor: 1.733

Review 4.  Biology of colorectal cancer.

Authors:  Francisco Arvelo; Felipe Sojo; Carlos Cotte
Journal:  Ecancermedicalscience       Date:  2015-04-09

5.  Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer.

Authors:  Stijn Crobach; Anne M L Jansen; Marjolein J L Ligtenberg; Marije Koopmans; Maartje Nielsen; Frederik J Hes; Juul T Wijnen; Winand N M Dinjens; Tom van Wezel; Hans Morreau
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

6.  The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.

Authors:  Ashwin A Dihal; Arnoud Boot; Eddy H van Roon; Melanie Schrumpf; Arantza Fariña-Sarasqueta; Marta Fiocco; Eliane C M Zeestraten; Peter J K Kuppen; Hans Morreau; Tom van Wezel; Judith M Boer
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

Review 7.  MUTYH the base excision repair gene family member associated with colorectal cancer polyposis.

Authors:  Seyed Mohammad Hossein Kashfi; Mina Golmohammadi; Faeghe Behboudi; Ehsan Nazemalhosseini-Mojarad; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.